Related references
Note: Only part of the references are listed.Interplay between FGF21 and insulin action in the liver regulates metabolism
Brice Emanuelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
FGF21-based pharmacotherapy - potential utility for metabolic disorders
Ruth E. Gimeno et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?
A. M. Arafat et al.
DIABETOLOGIA (2013)
Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319
Alexei Kharitonenkov et al.
PLOS ONE (2013)
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
Andrew C. Adams et al.
PLOS ONE (2013)
The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue
Andrew C. Adams et al.
MOLECULAR METABOLISM (2013)
Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant
Subhadra C. Gunawardana et al.
DIABETES (2012)
Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
Yang Xiao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
Murielle M. Veniant et al.
PLOS ONE (2012)
Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes
Xuan Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Leptin Deficiency Causes Insulin Resistance Induced by Uncontrolled Diabetes
Jonathan P. German et al.
DIABETES (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity
Eric D. Berglund et al.
ENDOCRINOLOGY (2009)
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
Varman T. Samuel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver
Shawn C. Burgess et al.
CELL METABOLISM (2007)
Molecular determinants of FGF-21 activity-synergy and cross-talk with PPAR gamma signaling
Julie S. Moyers et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Brown adipose tissue: Function and physiological significance
B Cannon et al.
PHYSIOLOGICAL REVIEWS (2004)
Insulin therapy in type 2 diabetes
S Mudaliar et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2001)
Share Paper
